Conan MacDougall

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint National estimates and predictors of prescription medication sample use in the United States, 1999-2005
    Conan MacDougall
    Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco, CA 94143 0622, USA
    J Am Pharm Assoc (2003) 50:677-85. 2010
  2. ncbi request reprint Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections
    Cindy A Loffler
    University of California, San Francisco Medical Center, 521 Parnassus Ave, C 152, San Francisco, CA 94122, USA
    Expert Rev Anti Infect Ther 5:961-81. 2007
  3. ncbi request reprint Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals
    Conan MacDougall
    Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298, USA
    Clin Infect Dis 41:435-40. 2005
  4. ncbi request reprint Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus
    Suzanne Phillips
    Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA
    Ann Pharmacother 41:13-20. 2007
  5. doi request reprint Trends in antibacterial use in US academic health centers: 2002 to 2006
    Amy L Pakyz
    Department of Pharmacy, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298 0533, USA
    Arch Intern Med 168:2254-60. 2008
  6. doi request reprint Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients
    Jason C Gallagher
    School of Pharmacy, Temple University, Philadelphia, Pennsylvania 19140, USA
    Pharmacotherapy 29:792-9. 2009
  7. ncbi request reprint Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy
    Ronald E Polk
    School of Pharmacy, Department of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298, USA
    Clin Infect Dis 44:664-70. 2007
  8. pmc Antimicrobial stewardship programs in health care systems
    Conan MacDougall
    Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia 23298, USA
    Clin Microbiol Rev 18:638-56. 2005
  9. doi request reprint Cethromycin: a promising new ketolide antibiotic for respiratory infections
    Sally Rafie
    Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, California, USA
    Pharmacotherapy 30:290-303. 2010
  10. doi request reprint Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison
    Conan MacDougall
    Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, California, USA
    Infect Control Hosp Epidemiol 29:203-11. 2008

Detail Information

Publications10

  1. doi request reprint National estimates and predictors of prescription medication sample use in the United States, 1999-2005
    Conan MacDougall
    Department of Clinical Pharmacy, School of Pharmacy, University of California at San Francisco, CA 94143 0622, USA
    J Am Pharm Assoc (2003) 50:677-85. 2010
    ..To determine the prevalence of free medication sample use in the United States and analyze the effects of socioeconomic status and drug safety actions...
  2. ncbi request reprint Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections
    Cindy A Loffler
    University of California, San Francisco Medical Center, 521 Parnassus Ave, C 152, San Francisco, CA 94122, USA
    Expert Rev Anti Infect Ther 5:961-81. 2007
    ..As MRSA becomes the 'new normal' in many areas, clinicians will have to sort out the proper role of a dozen or more anti-MRSA drugs...
  3. ncbi request reprint Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals
    Conan MacDougall
    Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298, USA
    Clin Infect Dis 41:435-40. 2005
    ..We performed an ecologic-level study to determine whether variability in hospital percentages of fluoroquinolone-resistant E. coli and MRSA were associated with fluoroquinolone use in hospitals and their surrounding communities...
  4. ncbi request reprint Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus
    Suzanne Phillips
    Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA
    Ann Pharmacother 41:13-20. 2007
    ..The threshold at which drugs active against MRSA, such as clindamycin and trimethoprim/sulfamethoxazole (TMP/SMX), should be incorporated into empiric therapy is unknown...
  5. doi request reprint Trends in antibacterial use in US academic health centers: 2002 to 2006
    Amy L Pakyz
    Department of Pharmacy, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298 0533, USA
    Arch Intern Med 168:2254-60. 2008
    ..The objectives of this study were to characterize trends in antibacterial use in a sample of US hospitals and to identify predictors of use...
  6. doi request reprint Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients
    Jason C Gallagher
    School of Pharmacy, Temple University, Philadelphia, Pennsylvania 19140, USA
    Pharmacotherapy 29:792-9. 2009
    ..To determine clinical and microbiologic outcomes of daptomycin for the treatment of bacteremia caused by vancomycin-resistant enterococci (VRE)...
  7. ncbi request reprint Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy
    Ronald E Polk
    School of Pharmacy, Department of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298, USA
    Clin Infect Dis 44:664-70. 2007
    ..The World Health Organization's recommended metric is the defined daily dose (DDD). An alternative measure is the number of days of therapy (DOT). The purpose of this study was to contrast these measures...
  8. pmc Antimicrobial stewardship programs in health care systems
    Conan MacDougall
    Department of Pharmacy, School of Pharmacy, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Virginia 23298, USA
    Clin Microbiol Rev 18:638-56. 2005
    ..When instituting an antimicrobial stewardship program, a hospital should tailor its choice of strategies to its needs and available resources...
  9. doi request reprint Cethromycin: a promising new ketolide antibiotic for respiratory infections
    Sally Rafie
    Department of Clinical Pharmacy, University of California at San Francisco, San Francisco, California, USA
    Pharmacotherapy 30:290-303. 2010
    ..Given current resistance levels, cethromycin could provide more reliable coverage against common respiratory pathogens than traditional agents in the beta-lactam and macrolide classes...
  10. doi request reprint Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison
    Conan MacDougall
    Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, California, USA
    Infect Control Hosp Epidemiol 29:203-11. 2008
    ..To describe variability in rates of antibacterial use in a large sample of US hospitals and to create risk-adjusted models for interhospital comparison...